| Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome E Shubbar, A Kovács, S Hajizadeh, TZ Parris, S Nemes, K Gunnarsdóttir, ... BMC cancer 13, 1-10, 2013 | 167 | 2013 |
| Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens P Larsson, H Engqvist, J Biermann, E Werner Rönnerman, ... Scientific reports 10 (1), 5798, 2020 | 153 | 2020 |
| Clinical implications of gene dosage and gene expression patterns in diploid breast carcinoma TZ Parris, A Danielsson, S Nemes, A Kovács, U Delle, G Fallenius, ... Clinical Cancer Research 16 (15), 3860-3874, 2010 | 141 | 2010 |
| Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11-p12-amplified breast carcinomas TZ Parris, A Kovacs, S Hajizadeh, S Nemes, M Semaan, M Levin, ... Oncogenesis 3 (3), e95-e95, 2014 | 80 | 2014 |
| Clinical relevance of breast cancer-related genes as potential biomarkers for oral squamous cell carcinoma TZ Parris, L Aziz, A Kovács, S Hajizadeh, S Nemes, M Semaan, CY Chen, ... BMC cancer 14, 1-11, 2014 | 79 | 2014 |
| Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma TZ Parris, A Kovács, L Aziz, S Hajizadeh, S Nemes, M Semaan, ... International journal of cancer 134 (7), 1617-1629, 2014 | 73 | 2014 |
| Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray E Möllerström, A Kovács, K Lövgren, S Nemes, U Delle, A Danielsson, ... BMC cancer 10, 1-11, 2010 | 47 | 2010 |
| Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas H Engqvist, TZ Parris, A Kovács, S Nemes, E Werner Rönnerman, ... BMC cancer 19, 1-12, 2019 | 46 | 2019 |
| Transcriptional response of BALB/c mouse thyroids following in vivo astatine-211 exposure reveals distinct gene expression profiles N Rudqvist, TZ Parris, E Schüler, K Helou, E Forssell-Aronsson EJNMMI research 2, 1-12, 2012 | 41 | 2012 |
| Early onset of inflammation during ontogeny of bipolar disorder: the NLRP2 inflammasome gene distinctly differentiates between patients and healthy controls in the transition … D Vizlin-Hodzic, Q Zhai, S Illes, K Södersten, K Truve, TZ Parris, ... Translational psychiatry 7 (1), e1010-e1010, 2017 | 37 | 2017 |
| Pan-cancer analysis identifies BIRC5 as a prognostic biomarker A Fäldt Beding, P Larsson, K Helou, Z Einbeigi, TZ Parris BMC cancer 22 (1), 322, 2022 | 35 | 2022 |
| Comparative analysis of transcriptional gene regulation indicates similar physiologic response in mouse tissues at low absorbed doses from intravenously administered 211At B Langen, N Rudqvist, TZ Parris, E Schüler, K Helou, E Forssell-Aronsson Journal of Nuclear Medicine 54 (6), 990-998, 2013 | 34 | 2013 |
| Prognostic significance of BIRC5/survivin in breast cancer: results from three independent cohorts N Oparina, MC Erlandsson, A Fäldt Beding, T Parris, K Helou, P Karlsson, ... Cancers 13 (9), 2209, 2021 | 33 | 2021 |
| Effects of internal low-dose irradiation from 131I on gene expression in normal tissues in Balb/c mice E Schüler, TZ Parris, N Rudqvist, K Helou, E Forssell-Aronsson EJNMMI research 1, 1-14, 2011 | 33 | 2011 |
| Hedgehog inhibitor sonidegib potentiates 177Lu-octreotate therapy of GOT1 human small intestine neuroendocrine tumors in nude mice J Spetz, B Langen, N Rudqvist, TZ Parris, K Helou, O Nilsson, ... BMC cancer 17, 1-11, 2017 | 30 | 2017 |
| Validation of novel prognostic biomarkers for early-stage clear-cell, endometrioid and mucinous ovarian carcinomas using immunohistochemistry H Engqvist, TZ Parris, A Kovács, EW Rönnerman, K Sundfeldt, P Karlsson, ... Frontiers in oncology 10, 162, 2020 | 29 | 2020 |
| Time-and dose rate-related effects of internal 177Lu exposure on gene expression in mouse kidney tissue E Schüler, N Rudqvist, TZ Parris, B Langen, J Spetz, K Helou, ... Nuclear medicine and biology 41 (10), 825-832, 2014 | 27 | 2014 |
| Dose-specific transcriptional responses in thyroid tissue in mice after 131I administration N Rudqvist, E Schüler, TZ Parris, B Langen, K Helou, E Forssell-Aronsson Nuclear medicine and biology 42 (3), 263-268, 2015 | 25 | 2015 |
| Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma TZ Parris, EW Rönnerman, H Engqvist, J Biermann, K Truvé, S Nemes, ... Oncotarget 9 (35), 24140, 2018 | 22 | 2018 |
| Transcriptional response of kidney tissue after 177Lu-octreotate administration in mice E Schüler, N Rudqvist, TZ Parris, B Langen, K Helou, E Forssell-Aronsson Nuclear medicine and biology 41 (3), 238-247, 2014 | 22 | 2014 |
Khalil Helouassociate professor, docent, university of gothenburgVerified email at oncology.gu.se
